Slentrol

RSS

Withdrawn

This medicine's authorisation has been withdrawn

dirlotapide
MedicineVeterinaryWithdrawn

Lithuanian is available via eTranslation, the European Commission's machine translation service.

Translate to Lithuanian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Slentrol has been withdrawn at the request of the marketing authorisation holder.

български (BG) (279.69 KB - PDF)

Rodyti

español (ES) (239.85 KB - PDF)

Rodyti

čeština (CS) (283.94 KB - PDF)

Rodyti

dansk (DA) (239 KB - PDF)

Rodyti

Deutsch (DE) (241.8 KB - PDF)

Rodyti

eesti (ET) (237.14 KB - PDF)

Rodyti

ελληνικά (EL) (282.67 KB - PDF)

Rodyti

français (FR) (245.68 KB - PDF)

Rodyti

italiano (IT) (238.08 KB - PDF)

Rodyti

latviešu (LV) (283.06 KB - PDF)

Rodyti

lietuvių (LT) (251.47 KB - PDF)

Rodyti

magyar (HU) (253.42 KB - PDF)

Rodyti

Malti (MT) (265.77 KB - PDF)

Rodyti

Nederlands (NL) (217.72 KB - PDF)

Rodyti

polski (PL) (282.55 KB - PDF)

Rodyti

português (PT) (218.29 KB - PDF)

Rodyti

română (RO) (242.81 KB - PDF)

Rodyti

slovenčina (SK) (260.4 KB - PDF)

Rodyti

slovenščina (SL) (252.65 KB - PDF)

Rodyti

suomi (FI) (237.94 KB - PDF)

Rodyti

svenska (SV) (239.22 KB - PDF)

Rodyti

Product information

български (BG) (1.12 MB - PDF)

Rodyti

español (ES) (413.23 KB - PDF)

Rodyti

čeština (CS) (559.01 KB - PDF)

Rodyti

dansk (DA) (619.26 KB - PDF)

Rodyti

Deutsch (DE) (409.78 KB - PDF)

Rodyti

eesti (ET) (394.94 KB - PDF)

Rodyti

ελληνικά (EL) (1.78 MB - PDF)

Rodyti

français (FR) (455.26 KB - PDF)

Rodyti

italiano (IT) (432.39 KB - PDF)

Rodyti

latviešu (LV) (543.86 KB - PDF)

Rodyti

lietuvių (LT) (475.04 KB - PDF)

Rodyti

magyar (HU) (577.53 KB - PDF)

Rodyti

Malti (MT) (631.26 KB - PDF)

Rodyti

Nederlands (NL) (419.67 KB - PDF)

Rodyti

polski (PL) (601.64 KB - PDF)

Rodyti

português (PT) (402.62 KB - PDF)

Rodyti

română (RO) (490.98 KB - PDF)

Rodyti

slovenčina (SK) (616.03 KB - PDF)

Rodyti

slovenščina (SL) (568.91 KB - PDF)

Rodyti

suomi (FI) (408.3 KB - PDF)

Rodyti

svenska (SV) (413.86 KB - PDF)

Rodyti

Íslenska (IS) (418.64 KB - PDF)

Rodyti

norsk (NO) (405.73 KB - PDF)

Rodyti
Latest procedure affecting product information:IAIN/0007/G
15/01/2015

български (BG) (202.54 KB - PDF)

Rodyti

español (ES) (148.22 KB - PDF)

Rodyti

čeština (CS) (192.56 KB - PDF)

Rodyti

dansk (DA) (151.57 KB - PDF)

Rodyti

Deutsch (DE) (152.17 KB - PDF)

Rodyti

eesti (ET) (147.88 KB - PDF)

Rodyti

ελληνικά (EL) (200.73 KB - PDF)

Rodyti

français (FR) (474.14 KB - PDF)

Rodyti

italiano (IT) (148.51 KB - PDF)

Rodyti

latviešu (LV) (202.11 KB - PDF)

Rodyti

lietuvių (LT) (191.42 KB - PDF)

Rodyti

magyar (HU) (188.69 KB - PDF)

Rodyti

Malti (MT) (194.75 KB - PDF)

Rodyti

Nederlands (NL) (151.46 KB - PDF)

Rodyti

polski (PL) (176.01 KB - PDF)

Rodyti

português (PT) (151.81 KB - PDF)

Rodyti

română (RO) (188.05 KB - PDF)

Rodyti

slovenčina (SK) (195.92 KB - PDF)

Rodyti

slovenščina (SL) (189.87 KB - PDF)

Rodyti

suomi (FI) (147.96 KB - PDF)

Rodyti

svenska (SV) (151.54 KB - PDF)

Rodyti

Íslenska (IS) (151.76 KB - PDF)

Rodyti

norsk (NO) (148.31 KB - PDF)

Rodyti

Product details

Name of medicine
Slentrol
Active substance
dirlotapide
International non-proprietary name (INN) or common name
dirlotapide
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QA08AB91

Pharmacotherapeutic group

Antiobesity preparations, excl. diet products

Therapeutic indication

As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight-management programme that also includes appropriate dietary changes and exercise practice.

Authorisation details

EMA product number
EMEA/V/C/000116
Marketing authorisation holder
Zoetis Belgium SA

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Marketing authorisation issued
13/04/2007
Revision
7

Assessment history

This page was last updated on

Share this page